The market for radioligand therapies is expected to grow significantly in the coming years. This is due to the increasing number of patients who are being ...

Copyright 2026 BBC. All rights reserved. The BBC is not responsible for the content of external sites. Read about our approach to external linking.

A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by ...